AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Beginning this month, Blossom Family Medicine will integrate OpenDNA’s CardioRisk+, CancerRisk+, and TotalRisk+ genetic testing solutions into its preventive care services. These tests combine advanced polygenic risk scoring with clinical and family history analysis to deliver a more complete and personalized view of an individual’s health risks.
“Partnering with OpenDNA aligns perfectly with our mission to deliver personalized, preventive, and patient-centered care,” said Dr. Jessica Marabella, Founder & Physician of Blossom Family Medicine. “By incorporating advanced, AI-driven genetic risk prediction into our practice, we’re empowering our patients with valuable insights to help guide their long-term health decisions.”
OpenDNA’s platform uses state-of-the-art machine learning algorithms and extensive genomic databases to generate high-accuracy risk scores. These scores support clinicians in tailoring screening, lifestyle recommendations, and preventive interventions based on each patient’s unique genetic profile.
“This collaboration represents an exciting step forward in making precision medicine more accessible at the primary care level,” said Dr. Eran Feldhay, Founder and CEO of OpenDNA. “Blossom Family Medicine’s commitment to innovation and whole-family wellness makes them an ideal partner.”
Patients interested in learning more about these new services or scheduling a consultation are encouraged to contact Blossom Family Medicine directly or visit www.blossomfamilymed.com.
About Blossom Family Medicine
Blossom Family Medicine is a concierge family medical practice located in Arlington Heights, Illinois, founded by Dr. Jessica Marabella. Dedicated to providing personalized, compassionate care for individuals and families, the practice operates on a membership-based model that emphasizes patient-centered attention. Blossom Family Medicine focuses on building meaningful relationships with patients to support their long-term wellness journeys.
About OpenDNA
OpenDNA is a precision medicine and AI company revolutionizing disease prediction and personalized healthcare through advanced polygenic and monogenic risk analysis. Its proprietary technology empowers providers to make informed, data-driven decisions that improve patient outcomes.
Nir Gamliel, CBO
OpenDNA
+1 2404019712
[email protected]
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
